New approach methodologies

New approach methodologies (NAMs) – such as advanced cell models and microtissues – are rapidly being adopted in the early stages of therapeutics development because they offer researchers more human-relevant models, advancing the 3Rs (replacement, reduction and refinement) of using animal models. NAMs encompass a wide range of tools from  in vitro to in  silico  models, offering a varied and innovative toolbox to replace outdated animal models.

In this In Focus, sponsored by Sartorius, gain an insight into the world of NAMs and how they are revolutionizing therapeutics development, including their challenges, solutions driving adoption and regulatory considerations.